Copyright Reports & Markets. All rights reserved.

Global Microneedle Drug Delivery Systems Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Microneedle Drug Delivery Systems Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Microneedle Drug Delivery Systems Market Size Growth Rate by Product
      • 1.4.2 Hollow Microneedle Technology
      • 1.4.3 Solid Microneedle Technology
      • 1.4.4 Dissolving Microneedles Technology
    • 1.5 Market by End User
      • 1.5.1 Global Microneedle Drug Delivery Systems Market Size Growth Rate by End User
      • 1.5.2 Drug Delivery
      • 1.5.3 Vaccine Delivery
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Microneedle Drug Delivery Systems Market Size
      • 2.1.1 Global Microneedle Drug Delivery Systems Revenue 2014-2025
      • 2.1.2 Global Microneedle Drug Delivery Systems Sales 2014-2025
    • 2.2 Microneedle Drug Delivery Systems Growth Rate by Regions
      • 2.2.1 Global Microneedle Drug Delivery Systems Sales by Regions
      • 2.2.2 Global Microneedle Drug Delivery Systems Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Microneedle Drug Delivery Systems Sales by Manufacturers
      • 3.1.1 Microneedle Drug Delivery Systems Sales by Manufacturers
      • 3.1.2 Microneedle Drug Delivery Systems Sales Market Share by Manufacturers
      • 3.1.3 Global Microneedle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.2 Microneedle Drug Delivery Systems Revenue by Manufacturers
      • 3.2.1 Microneedle Drug Delivery Systems Revenue by Manufacturers (2014-2019)
      • 3.2.2 Microneedle Drug Delivery Systems Revenue Share by Manufacturers (2014-2019)
    • 3.3 Microneedle Drug Delivery Systems Price by Manufacturers
    • 3.4 Microneedle Drug Delivery Systems Manufacturing Base Distribution, Product Types
      • 3.4.1 Microneedle Drug Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Microneedle Drug Delivery Systems Product Type
      • 3.4.3 Date of International Manufacturers Enter into Microneedle Drug Delivery Systems Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Microneedle Drug Delivery Systems Sales by Product
    • 4.2 Global Microneedle Drug Delivery Systems Revenue by Product
    • 4.3 Microneedle Drug Delivery Systems Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Microneedle Drug Delivery Systems Breakdown Data by End User

    6 North America

    • 6.1 North America Microneedle Drug Delivery Systems by Countries
      • 6.1.1 North America Microneedle Drug Delivery Systems Sales by Countries
      • 6.1.2 North America Microneedle Drug Delivery Systems Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Microneedle Drug Delivery Systems by Product
    • 6.3 North America Microneedle Drug Delivery Systems by End User

    7 Europe

    • 7.1 Europe Microneedle Drug Delivery Systems by Countries
      • 7.1.1 Europe Microneedle Drug Delivery Systems Sales by Countries
      • 7.1.2 Europe Microneedle Drug Delivery Systems Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Microneedle Drug Delivery Systems by Product
    • 7.3 Europe Microneedle Drug Delivery Systems by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Microneedle Drug Delivery Systems by Countries
      • 8.1.1 Asia Pacific Microneedle Drug Delivery Systems Sales by Countries
      • 8.1.2 Asia Pacific Microneedle Drug Delivery Systems Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Microneedle Drug Delivery Systems by Product
    • 8.3 Asia Pacific Microneedle Drug Delivery Systems by End User

    9 Central & South America

    • 9.1 Central & South America Microneedle Drug Delivery Systems by Countries
      • 9.1.1 Central & South America Microneedle Drug Delivery Systems Sales by Countries
      • 9.1.2 Central & South America Microneedle Drug Delivery Systems Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Microneedle Drug Delivery Systems by Product
    • 9.3 Central & South America Microneedle Drug Delivery Systems by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Microneedle Drug Delivery Systems by Countries
      • 10.1.1 Middle East and Africa Microneedle Drug Delivery Systems Sales by Countries
      • 10.1.2 Middle East and Africa Microneedle Drug Delivery Systems Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Microneedle Drug Delivery Systems by Product
    • 10.3 Middle East and Africa Microneedle Drug Delivery Systems by End User

    11 Company Profiles

    • 11.1 3M
      • 11.1.1 3M Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 3M Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 3M Microneedle Drug Delivery Systems Products Offered
      • 11.1.5 3M Recent Development
    • 11.2 Zosano Pharma
      • 11.2.1 Zosano Pharma Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Zosano Pharma Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Zosano Pharma Microneedle Drug Delivery Systems Products Offered
      • 11.2.5 Zosano Pharma Recent Development
    • 11.3 Becton-Dickinson(BD)Technologies
      • 11.3.1 Becton-Dickinson(BD)Technologies Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Products Offered
      • 11.3.5 Becton-Dickinson(BD)Technologies Recent Development
    • 11.4 Nanopass Technologies
      • 11.4.1 Nanopass Technologies Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Products Offered
      • 11.4.5 Nanopass Technologies Recent Development
    • 11.5 Corium
      • 11.5.1 Corium Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Corium Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Corium Microneedle Drug Delivery Systems Products Offered
      • 11.5.5 Corium Recent Development
    • 11.6 Valeritas
      • 11.6.1 Valeritas Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Valeritas Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Valeritas Microneedle Drug Delivery Systems Products Offered
      • 11.6.5 Valeritas Recent Development
    • 11.7 Nitto
      • 11.7.1 Nitto Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Nitto Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Nitto Microneedle Drug Delivery Systems Products Offered
      • 11.7.5 Nitto Recent Development
    • 11.8 Microdermics
      • 11.8.1 Microdermics Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Microdermics Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Microdermics Microneedle Drug Delivery Systems Products Offered
      • 11.8.5 Microdermics Recent Development
    • 11.9 TheraJect, Inc
      • 11.9.1 TheraJect, Inc Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Products Offered
      • 11.9.5 TheraJect, Inc Recent Development
    • 11.10 Vaxxas
      • 11.10.1 Vaxxas Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Vaxxas Microneedle Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Vaxxas Microneedle Drug Delivery Systems Products Offered
      • 11.10.5 Vaxxas Recent Development
    • 11.11 Lohmann Therapie-Systeme AG

    12 Future Forecast

    • 12.1 Microneedle Drug Delivery Systems Market Forecast by Regions
      • 12.1.1 Global Microneedle Drug Delivery Systems Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Microneedle Drug Delivery Systems Revenue Forecast by Regions 2019-2025
    • 12.2 Microneedle Drug Delivery Systems Market Forecast by Product
      • 12.2.1 Global Microneedle Drug Delivery Systems Sales Forecast by Product 2019-2025
      • 12.2.2 Global Microneedle Drug Delivery Systems Revenue Forecast by Product 2019-2025
    • 12.3 Microneedle Drug Delivery Systems Market Forecast by End User
    • 12.4 North America Microneedle Drug Delivery Systems Forecast
    • 12.5 Europe Microneedle Drug Delivery Systems Forecast
    • 12.6 Asia Pacific Microneedle Drug Delivery Systems Forecast
    • 12.7 Central & South America Microneedle Drug Delivery Systems Forecast
    • 12.8 Middle East and Africa Microneedle Drug Delivery Systems Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Microneedle Drug Delivery Systems Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Microneedle drug delivery systems usually include hollow microneedle and solid microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
      Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
      Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
      The global Microneedle Drug Delivery Systems market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Microneedle Drug Delivery Systems market based on company, product type, end user and key regions.

      This report studies the global market size of Microneedle Drug Delivery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Microneedle Drug Delivery Systems in these regions.
      This research report categorizes the global Microneedle Drug Delivery Systems market by top players/brands, region, type and end user. This report also studies the global Microneedle Drug Delivery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      3M
      Zosano Pharma
      Becton-Dickinson(BD)Technologies
      Nanopass Technologies
      Corium
      Valeritas
      Nitto
      Microdermics
      TheraJect, Inc
      Vaxxas
      Lohmann Therapie-Systeme AG

      Market size by Product
      Hollow Microneedle Technology
      Solid Microneedle Technology
      Dissolving Microneedles Technology
      Market size by End User
      Drug Delivery
      Vaccine Delivery
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Microneedle Drug Delivery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Microneedle Drug Delivery Systems market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Microneedle Drug Delivery Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Microneedle Drug Delivery Systems submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Microneedle Drug Delivery Systems are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Microneedle Drug Delivery Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now